Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV10 and PCV13 dosing schedules in South African children
NCT02943902Phase 3Completed
- Sponsor
- University of the Witwatersrand
- Start
- Jan 2017
- Primary completion
- Feb 2019
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine, pneumococcal 13-valent conjugate vaccine in pneumonia, meningitis, sponsored by University of the Witwatersrand. Started Jan 2017; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
pneumoniameningitis
Beyond the preview
Go deeper on NCT02943902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943902.